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Altered cerebral regulation in type 2 diabetic patients
with cardiac autonomic neuropathy
H. Marthol & C. M. Brown & U. Zikeli & D. Ziegler &
N. Dimitrov & R. Baltadzhieva & M. J. Hilz
Abstract
Aims/hypothesis Assessment of cerebral regulation in dia-
betic patients is often problematic because of the presence
of cardiac autonomic neuropathy. We evaluated the tech-
nique of oscillatory neck suction at 0.1 Hz to quantify
cerebral regulation in diabetic patients and healthy control
subjects.
Subjects and methods In nine type 2 diabetic patients with
cardiac autonomic neuropathy and 11 age-matched con-
trols, we measured blood pressure and cerebral blood flow
velocity responses to application of 0.1 Hz neck suction.
We determined spectral powers and calculated the transfer
function gain and phase shift between 0.1 Hz blood
pressure and cerebral blood flow velocity oscillations as
parameters of cerebral regulation.
Results In the patients and control subjects, neck suction
did not significantly influence mean values of the RR
interval, blood pressure and cerebral blood flow velocity.
The powers of 0.1 Hz blood pressure and cerebral blood
flow velocity oscillations increased in the control subjects,
but remained stable in the patients. Transfer function gain
remained stable in both groups. Phase shift decreased in the
patients, but remained stable in control subjects.
Conclusions/interpretation The absence of an increase in
the power of 0.1 Hz blood pressure and cerebral blood flow
velocity oscillations confirmed autonomic neuropathy in
the diabetic patients. Gain analysis did not show altered
cerebral regulation. The decrease in phase shift in the
patients indicates a more passive transmission of neck
suction-induced blood pressure fluctuations onto the cere-
brovascular circulation, i.e. altered cerebral regulation, in
the patients, and is therefore suited to identifying subtle
impairment of cerebral regulation in these patients.
Keywords Autonomic neuropathy . Heart rate variability .
Phase shift . Spectral analysis . Sympathetic nervous system .
Transfer function gain
Abbreviations
CBFV Cerebral blood flow velocity
Introduction
Patients with diabetes mellitus are at high risk of cerebro-
vascular complications. In patients with type 2 diabetes the
incidence of stroke is two- to five-fold higher than in
healthy individuals [1]. Strokes in diabetic patients are
probably due to microangiopathy rather than to atheroscle-
rosis of the large arteries or cardioembolism [2]. Moreover,
it has been suggested that autonomic neuropathy is an
independent risk factor for strokes in patients with type 2
diabetes [3]. Both vascular disease and autonomic dysfunc-
tion in diabetic patients might contribute to compromised
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cerebral regulation, thereby further increasing the risk of
cerebrovascular complications [4]. Assessment of cerebral
regulation in diabetic patients is therefore important to help
identify whether there is an increased risk of cerebrovascular
complications [4].
Cardiovascular autonomic neuropathy is a common
complication of diabetes mellitus. Patients with type 2
diabetes have impaired heart rate responses to standard
autonomic tests, a phenomenon that is associated with
increased cardiovascular risk and mortality [5, 6]. One
method of assessing cardiovascular autonomic function is
to stimulate the carotid baroreceptors directly using
oscillatory neck suction [7]. In normal subjects, oscillations
in baroreceptor activity induced by neck suction at 0.1 Hz
induce oscillations in heart rate and blood pressure at the
same frequency. We previously demonstrated that the reflex
heart rate and blood pressure responses to 0.1 Hz oscilla-
tory neck suction were reduced in patients with type 2
diabetes [8]. Therefore, in addition to impaired cardiovagal
control, patients with type 2 diabetes also show deteriora-
tion in the regulation of peripheral vascular tone.
The term ‘cerebral regulation’ refers to the mechanisms
by which cerebral blood flow remains relatively constant
even during large variations in blood pressure. The testing
of cerebral regulation is based on the evaluation of
cerebrovascular responses to changes in blood pressure.
So far, blood pressure changes have been induced either by
drugs such as angiotensin, phenylephrine and sodium
nitroprusside, or by challenge manoeuvres such as ortho-
static challenge, the leg-cuff-method according to Aaslid,
metronomic breathing or the Valsalva manoeuvre [9]. In
patients with prominent autonomic neuropathy, compro-
mised adaptation of heart rate and blood pressure and
particularly pronounced orthostatic hypotension may pro-
vide inadequate conditions for testing of cerebral regula-
tion. Therefore, standard manoeuvres might be unsuitable
for quantifying cerebral regulation in such patients. The
method of sinusoidal neck suction, however, provides a
refined approach to the testing of cerebral regulation [10].
Using this approach, a neck chamber is fitted over the
participants’ neck and subatmospheric pressure is applied in
a sinusoidal manner [11]. The subsequent rhythmical
deformation of the arterial vessels alternately activates and
deactivates the carotid baroreceptors. Neck suction at
0.1 Hz generates vasomotor fluctuations at 0.1 Hz not only
in the peripheral but also in the cerebral blood vessels [10]
and is therefore suited to evaluating the transfer of
sympathetically mediated 0.1 Hz oscillations in blood
pressure onto 0.1 Hz oscillations in CBFV, i.e. cerebral
regulation.
Based on the findings of impaired autonomic and
vascular regulation in patients with type 2 diabetes, one
might also expect cerebral regulation to be affected. In this
study we therefore extended our previous observations in
the 14 patients with type 2 diabetes in whom we had
assessed cardiovagal and vasomotor responses to sinusoidal
neck suction [8]. The main objective of the present analysis
was to evaluate blood pressure and cerebral blood flow
velocity signals to determine whether the behaviour of the
cerebral blood vessels differs in patients with type 2 diabetes
patients and definite autonomic neuropathy compared with a
group of healthy control subjects.
Subjects and methods
Subjects
This study comprised an evaluation of data previously
obtained from 14 patients who had been diagnosed with
type 2 diabetes mellitus according to the internationally
accepted criteria of the American Diabetes Association and
the World Health Organization. All patients underwent a
battery of standard cardiovascular reflex tests. These
comprised assessment of heart rate variability at rest and
during metronomic breathing, the Valsalva manoeuvre and
active standing [12]. Nine of the patients fulfilled the
criteria of severe cardiac autonomic neuropathy, defined as
two or more pathological results from standard cardiovas-
cular reflex testing, and were therefore included in the
present analysis. The mean±SD age of the nine patients was
56.2±5.4 years, duration of diabetes 84.1±51.3 months,
weight 81.0±17.5 kg, height 170.8±8.5 cm and BMI 27.6±
4.0 kg/m2. To largely control for a possible influence of
prevailing poor glycaemic control, patients with HbA1c
levels above 7.7% were excluded. The individual HbA1c
levels were 6.9% (n=2), 7.2% (n=2), 7.3% (n=1), 7.4%
(n=1), 7.5% (n=2) and 7.7% (n=1), respectively. Four
patients were treated with insulin and five patients were on
oral antidiabetic drugs such as sulfonylureas or metformin.
All participants had a light meal 3 to 4 h before testing. To
ensure the absence of hypoglycaemia within 24 h prior to
testing, all patients self-monitored their blood glucose at
least three times 1 h after meals. The postprandial blood
glucose levels were below 7.8 mmol/l, without evidence of
hypoglycaemia. None of the diabetic patients showed any
symptoms or signs of diabetic somatic neuropathy. Two
patients occasionally suffered from symptoms of orthostatic
intolerance, such as postural dizziness or blurred vision.
We also tested 11 healthy controls (mean age 54.5±
10.0 years, weight 77.7±17.2 kg, height 170.0±7.5 cm,
BMI 26.6±4.3 kg/m2). The controls were recruited from
healthy friends and relatives of staff members and patients.
None of the participants had a history of chronic alcohol
abuse, carcinoma of any origin, myopathy, hyper- or hy-
pothyroidism, arterial hypertension, cardiac arrhythmia,
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atherosclerosis, previous kidney or pancreas transplanta-
tion, significant hepatic or renal disease or any other
condition that would interfere with their ability to partici-
pate in the study. Apart from insulin or oral antidiabetics in
the diabetic patients, none of the participants was on any
other medication known to influence the cardiovascular or
autonomic systems. The participants were instructed to
refrain from nicotine, caffeine or alcohol for 24 h prior to
the measurements.
Before the testing procedure, each control and patient
underwent duplex sonographic examination of the extra-
cranial arteries to rule out atherosclerosis and significant
stenoses of the carotid arteries.
The study was approved by the University of Erlangen-
Nuremberg Ethics Committee and written informed consent
was obtained according to the Declaration of Helsinki.
Procedures
Studies were performed in a quiet room with an ambient
temperature of 24°C and stable humidity. Each control
subject and patient initially rested in a supine position for at
least 45 min to ensure cardiovascular stability. Then we
recorded a continuous electrocardiogram and non-invasive
arterial blood pressure by radial artery tonometry (Colin
Pilot™; Colin Medical Instruments, San Antonio, TX,
USA). The blood pressure values were calibrated by
reference to automatic oscillometric cuff measurement of
the brachial artery. Mean cerebral blood flow velocity
(CBFV) of the left proximal middle cerebral artery was
assessed by transcranial Doppler sonography (Multidop
XL; DWL, Sipplingen, Germany). The middle cerebral
artery was insonated through the temporal window
approximately 1 cm above the zygomatic arch at a depth
of 35–55 mm using a 2-MHz Doppler probe. After
optimising the Doppler signal, the probe was attached to
the skull at a fixed angle using a headband with an
adjustable positioning system. Respiratory frequency was
monitored by means of inductance plethysmography using
two calibrated belts attached around the thorax and
abdomen (Respitrace Calibrator; Ambulatory Monitoring,
Ardsley, NY, USA) [13].
Baroreceptor stimulation
Responses of blood pressure and CBFV to baroreceptor
stimulation were determined using a method previously
described by Bernardi et al. [14]. The neck chamber
consisted of a malleable lead collar edged with neoprene
foam and was fitted to the anterior neck, over the carotid
baroreceptors. Subatmospheric pressure was applied to the
collar by means of a vacuum cleaner whose power output
was regulated through a control unit. Pressure within the
chamber was monitored with a pressure transducer (Hugo-
Sachs Elektronik, March, Germany) and could be set to
oscillate between 0 and 30 mmHg at 0.1 Hz. Breathing was
paced at 15 breaths/min (0.25 Hz) to avoid the effects of
respiratory interference on cardiovascular autonomic modu-
lation during the 0.1 Hz neck suction stimulation [7, 14, 15].
To familiarise the study participants with the respiratory
frequency prior to the study, they were taught to follow
visual and verbal signals to inspire and expire within 4 s,
i.e. close to their normal respiratory frequency.
An initial 5 min baseline recording was made during
0.25 Hz paced breathing without neck suction. The 0.1 Hz
neck suction stimulation was then performed for 3 min,
with breathing paced at 0.25 Hz throughout [7, 14, 15].
All data were digitised by a custom-made analogue-to-
digital converter at a sampling rate of 300 Hz and fed to a
Macintosh PowerBook computer (Apple), manually
cleaned from artefacts by linear interpolation and stored
for off-line analysis [14]. A C-language program identified
all QRS complexes in each sequence, located the peak of
each R wave and calculated consecutive RR intervals. From
the continuous waveforms of all parameters, beat-to-beat
mean values were automatically calculated and interpolated
linearly between adjacent values to construct a
corresponding continuous time series [14].
From a 60 s interval at baseline and during 0.1 Hz neck
suction, we calculated the mean and standard deviation of
all biosignals.
Fluctuations in RR intervals, blood pressure, CBFV,
respiration and pressure within the neck chamber were
characterised by applying power spectrum analysis to these
signals using an autoregressive algorithm with a linear
detrending option and model order estimation according to
Akaike information criteria [14, 16]. Spectral power refers
to the amount of variability of a signal (e.g. blood pressure
or CBFV) at a specific frequency. It is assessed as the
magnitude of the oscillations at a given frequency and is
expressed as units2 [17].
Autoregressive spectral analysis not only allows the
quantitative evaluation of cardiovascular regulation in
humans by assessing spontaneous oscillations in various
biosignals, but also provides information about the trans-
mission of neck suction-induced 0.1 Hz oscillations in
various biosignals.
Neck suction applied at 0.1 Hz transmits oscillations at
0.1 Hz to the level of the RR interval, blood pressure and
CBFV [14]. The response to 0.1 Hz neck suction at the
level of blood pressure and CBFV is an index of
sympathetic baroreceptor activation, and the response to
0.1 Hz neck suction at the RR interval level reflects
sympathetic and/or vagal effects of baroreceptor stimulation
on the heart [14]. We assessed the response to 0.1 Hz neck
suction as the change in spectral power at 0.1 Hz in the RR
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interval, blood pressure and CBFV compared with the
baseline value [14].
Cerebral regulation dampens the transmission of low-
frequency fluctuations of blood pressure onto the CBFV
but not high-frequency blood pressure fluctuations [14]. To
assess dynamic cerebral regulation, we calculated the
transfer function gain and the phase shift between blood
pressure and CBFV oscillations at 0.1 Hz as a measure of
the transmission of the 0.1 Hz neck suction-induced blood
pressure fluctuations on CBFV, provided there was signif-
icant coherence between the two signals [11, 18, 19].
The coherence between blood pressure and CBFV signal
oscillations might span from 0 (no association) to 1 (maximal
association) [14]. Two signals were considered to have a
stable phase relation for a given frequency of oscillation if
coherence was above 0.5. The gain was calculated between
CBFV and blood pressure oscillations as the square root of
the ratio of the 0.1 Hz power of CBFV divided by the 0.1 Hz
power of blood pressure [11].
Statistical analysis
All values are presented as mean±SEM. Significance was
assumed for p values below 0.05. In each group, we
compared differences between parameters at baseline and
during 0.1 Hz neck suction by means of the t-test for
dependent samples. In addition, we compared the parame-
ters obtained in the patients with the parameters obtained in
the controls using the t-test for independent samples. A
commercially available statistical program (SPSS; SPSS,
Chicago, IL, USA) was used for data analysis.
Results
Table 1 shows the resting cardiovascular state in the
controls and patients. There were no significant differences
in mean blood pressure, mean CBFV or their spectral
powers between the controls and the patients with type 2
diabetes. Resting heart rate was, however, significantly
higher in the patients with type 2 diabetes than in the
healthy controls (p=0.033). The transfer function gain
between mean blood pressure and cerebral blood flow
velocity did not differ significantly between patients and
controls (p=0.353), but there was a significant difference in
the phase relation between these two signals (p=0.008).
Table 2 shows the responses to 0.1 Hz neck suction in
the control subjects and patients. Application of 0.1 Hz
neck suction did not significantly change the mean values
of heart rate, blood pressure or CBFV in either the patients
with type 2 diabetes or the control subjects. In the healthy
volunteers, neck suction increased the 0.1 Hz powers of RR
intervals, mean blood pressure and CBFV (Fig. 1). The
measures of cerebral regulation (the transfer function gain
between 0.1 Hz blood pressure and CBFV oscillations as
well as the phase shift) remained stable during 0.1 Hz neck
suction (Fig. 2). In the patients with type 2 diabetes, 0.1 Hz
neck suction did not significantly increase the 0.1 Hz power
of RR intervals, mean blood pressure and CBFV (Fig. 1).
As in the control subjects, there were no changes in transfer
function gain between 0.1 Hz blood pressure and CBFV
oscillations during neck suction. In contrast, the phase shift
between 0.1 Hz blood pressure and CBFV oscillations in
the patients with type 2 diabetes was significantly lower
during neck suction than at baseline (Fig. 2). Whereas the
phase shift was lower during neck suction than at baseline
in the patients, the absolute value during neck suction was
not different from the value of the controls (Fig. 2).
Discussion
In the present study we extended our previous observa-
tions in 14 patients with type 2 diabetes in whom we
had previously assessed cardiovagal and vasomotor
responses to oscillatory neck suction [8]. To ensure that
the patients had pronounced autonomic neuropathy, we
included only the nine of the original 14 patients who
definitely fulfilled the criteria of severe cardiac autonomic
neuropathy, defined as pathological results in at least two of
the standardised cardiovascular tests [12]. Cerebral blood
flow velocity was recorded in the original study, but
cerebral blood flow data were not analysed and included
in our previous publication [8].
Table 1 Parameters at baseline
in the 11 healthy controls and
the nine patients with type 2
diabetes
All values are presented as
mean (SEM)
BP Blood pressure, CBFV
cerebral blood flow velocity
Parameter Controls Patients t-test
RR interval (ms) 916.9 (48.0) 771.5 (36.9) p=0.033
0.1 Hz power of RR interval (ms2) 84.9 (20.0) 48.6 (10.6) p=0.151
Mean BP (mmHg) 93.1 (2.8) 91.0 (2.6) p=0.595
Hz power of mean BP (mmHg) 0.6 (0.1) 0.8 (0.3) p=0.534
Mean CBFV (cm/s) 39.8 (3.6) 32.7 (4.2) p=0.217
0.1 Hz power of mean CBFV (cm2/s2) 0.6 (0.2) 0.7 (0.2) p=0.638
Transfer function gain (cm s−1 mmHg−1) 1.1 (0.1) 1.6 (0.6) p=0.353
Phase shift (rad) –1.1 (0.1) –1.7 (0.2) p=0.008
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To our knowledge, this is the first study evaluating
cerebrovascular regulation in type 2 diabetes by means of
sinusoidal neck suction.
Cerebrovascular regulation refers to the intrinsic ability
of the cerebral blood vessels to maintain a near-constant
cerebral blood flow despite changes in perfusion pressure,
provided the blood pressure remains within certain limits
(50–150 mmHg). Several mechanisms are thought to
contribute to cerebrovascular regulation. These include a
myogenic component as well as various neurohumoral,
metabolic (CO2 and H
+) and endothelial mechanisms [9].
The effect of sympathetic activation on cerebral circulation
has been the object of extensive debate. Panerai et al.
considered the sympathetic tone of cerebral arteries to be
minimal under normal conditions [20]. However, Zhang et
al. [21] and Ohta et al. [22] reported that the autonomic
nervous system plays an essential role in the autoregulatory
mechanisms of cerebral circulation. Diabetic patients have
been shown to have endothelial dysfunction and other
microvascular abnormalities. It is therefore possible that in
addition to dysfunctional autonomic regulation of the blood
vessels, diabetic patients have impaired mechanisms ensur-
ing constancy of cerebral blood flow.
Our main finding was that, in patients with type 2
diabetes who have severe cardiac autonomic neuropathy,
the mechanisms ensuring constancy of cerebral blood flow
seem to be altered compared with healthy control subjects.
Under resting conditions and during neck suction applica-
tion, the mean value of CBFV, the power of CBFV
oscillations and the transfer function gain did not differ
between the controls and the patients.
The transfer function gain is well established for the
assessment of cerebrovascular regulation and provides an
analysis of cerebrovascular responses to sinusoidal neck
suction. The gain was determined from the transfer function
of mean blood pressure oscillations as the input signal and
mean CBFVoscillations as the output signal. A low transfer
function gain indicates strong buffering of blood pressure
fluctuations by cerebral resistance vessels, i.e. intact
cerebrovascular regulation [11, 19]. The transfer function
gain reflects the extent to which there is a transmission of
blood pressure fluctuations onto CBFV fluctuations or a
buffering of such fluctuations by the mechanisms ensuring
constancy of cerebral blood flow [11, 19]. As the patients
showed values of the transfer function gain similar to those
of the healthy controls, the ability of the cerebral blood
vessels to buffer fluctuations in systemic blood pressure
seems to be intact in the patients with type 2 diabetes.
However, baroreceptor stimulation did not increase the
magnitude of blood pressure oscillations in the patients
with type 2 diabetes. Therefore, a subsequent change in the
power of CBFV would not be expected. Thus, the transfer
function gain is probably not an adequate method of
assessing cerebrovascular regulation in patients with type
2 diabetes.
Table 2 Responses to 0.1 Hz neck suction in the 11 healthy controls
and the nine patients with type 2 diabetes
Parameter Controls Patients t-test
RR interval (ms) 6.55 (9.00) 1.61 (7.36) p=0.685
0.1 Hz power of RR
interval (ms2)
110.23 (53.27) 93.62 (65.79) p=0.845
Mean BP (mmHg) −0.58 (1.15) −0.22 (0.92) p=0.812
1.2 Hz power of mean
BP (mmHg2)
0.83 (0.25) 0.02 (0.25) p=0.040
Mean CBFV (cm/s) −3.84 (1.53) −1.72 (0.88) p=0.275
0.1 Hz power of mean
CBFV (cm2/s2)
0.86 (0.33) −0.08 (0.15) p=0.025
Transfer function gain
(cm s−1 mmHg−1)
0.09 (0.15) −0.62 (0.58) p=0.210
Phase shift (rad) 0.11 (0.12) 0.56 (0.12) p=0.021
Data are presented as absolute differences between parameters at rest
and during 0.1 Hz neck suction.
All values are presented as mean (SEM)
CBFV Cerebral blood flow velocity
Fig. 1 Influence of 0.1 Hz neck suction on the sympathetically
mediated 0.1 Hz powers of (a) mean blood pressure (mmHg) and (b)
mean cerebral blood flow velocity (CBFV) (cm2 s−2) in the nine
patients with type 2 diabetes and the 11 healthy controls. In the
healthy controls, neck suction typically increased the 0.1 Hz powers of
blood pressure and CBFV. In the patients, however, 0.1 Hz neck
suction did not induce the typical increase in the 0.1 Hz powers of
blood pressure and CBFV, suggesting deficient sympathetic vasomo-
tor control. Open bars Blood pressure and CBFV before 0.1 Hz neck
suction; filled bars blood pressure and CBFV during 0.1 Hz neck
suction. *p<0.05
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In addition, the phase relation between oscillations in
mean blood pressure and mean CBFV can be used to
determine the quality of the mechanisms ensuring constan-
cy of cerebral blood flow. Diehl et al. showed that blood
pressure oscillations induced by metronomic breathing at 6
cycles/min generate oscillations in the CBFV signal at the
same frequency, which are not only dampened but also
shifted to the left because of the high-pass filter character-
istics of the mechanisms ensuring constancy of cerebral
blood flow [11, 18]. A rise in blood pressure—induced by
metronomic breathing—normally induces counter-regula-
tion of the vascular resistance bed with vasoconstriction.
Because of the vasoconstriction, CBFV has reached its
maximum before blood pressure is at its highest level.
While blood pressure approaches its maximum, there is
already a slowing of CBFV. When blood pressure starts to
decline, CBFV declines even faster as the response of the
cerebral resistance vessels to the preceding rise in blood
pressure persists. When blood pressure declines further, the
cerebrovascular system counteracts any further decrease in
CBFV by vasodilatation. Again, the minimum CBFV
precedes the minimum blood pressure. Consequently, there
is a recovery of CBFV before the next increase in blood
pressure. The relation between the leading CBFV and
lagging blood pressure oscillations can be described by
calculating the phase shift between the two signals [11, 18].
Analysis of this phase shift, i.e. the time delay between the
oscillations in blood pressure and CBFV, revealed some
differences in the behaviour of the mechanisms ensuring
constancy of cerebral blood flow between the controls and
the patients with type 2 diabetes. At rest, the phase shift
between mean blood pressure and CBFV was greater in the
patients than in the controls. Baroreflex stimulation with
0.1 Hz neck suction decreased the phase shift significantly
in the patients, but only slightly in the controls. According
to Diehl et al., the phase shift between blood pressure and
CBFVoscillations during deep breathing at 6 breaths/min in
healthy subjects is between 30 and 90° (equal to 0.52 and
1.57 rad). A decrease of the phase angle below such normal
values indicates a more passive behaviour of the cerebral
vessel bed and might indicate impaired cerebrovascular
regulation [18]. In patients with high-grade cerebral artery
stenoses, the phase angle between the two biosignals is
reduced or even absent, i.e. the CBFV oscillations are
driven passively by blood pressure oscillations and there is
no longer any filtering by the mechanisms ensuring
constancy of cerebral blood flow [18].
The phase shift results in our study are at slight variance
with the results reported by Cencetti et al. [23]. During
head-up tilt, Cencetti et al. observed a significant reduction
in phase shift in their controls [23]. This shortening of
phase shift was ascribed to sympathetic activation and
subsequent sympathetically mediated vessel stiffening [23].
In our controls, sympathetic challenge with 0.1 Hz neck
suction also decreased the phase shift, but the decrease was
only slight and not significant. Cerebrovascular regulation
prevented substantial changes in the phase shift. Another
possible explanation for this slight difference might be the
different stimuli used in the two studies. In our study, we
used sinusoidal neck suction, which is a repetitive stimulus,
while Cencetti et al. evaluated cerebrovascular responses to
continuous orthostatic challenge.
Although the phase shift in the controls differs only
slightly between the two studies, major differences are
evident in the results of the patients. Cencetti et al. reported
a lower phase shift at rest in the patients than the controls
[23]. In contrast, our patients had a bigger phase shift
before neck suction than the controls. We assume that our
patients had diabetic autonomic neuropathy at a later stage
of the disease and the stiffening, i.e. sympathetic tone, was
already more compromised than in the patients of Cencetti
et al. Because of the poor sympathetic outflow, the phase
shift is already rather high at rest. With 0.1 Hz neck suction
the cerebral regulatory system of our diabetic patients
Fig. 2 Transfer function gain (a) and phase shift (b) between mean
blood pressure and mean cerebral blood flow velocity oscillations at
0.1 Hz in 11 healthy controls and nine patients with type 2 diabetes
before and during 0.1 Hz neck suction. In the patients, 0.1 Hz neck
suction did not change the transfer function gain since sympathetic
dysfunction prevented any increase in the spectral power of blood
pressure at 0.1 Hz, i.e. in the input signal of cerebral regulation. The
phase shift analysis, however, revealed a decrease in the patients,
indicating altered cerebral regulation. Open bars Gain and phase shift
before 0.1 Hz neck suction; filled bars gain and phase shift during
0.1 Hz neck suction. *p<0.05
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cannot maintain the initial phase shift. Perhaps, there is a
relative, positive forward shift as a result of passive
transmission of blood pressure fluctuations, as described
by Cencetti et al. This relative passive component may
decrease the negative phase shift values seen at rest.
Our finding of a greater phase shift in patients with type
2 diabetes under resting conditions, along with the decrease
in the phase shift during 0.1 Hz neck suction, might
indicate altered cerebrovascular regulation during barore-
ceptor stimulation in patients with type 2 diabetes. Our
diabetic patients were previously shown to have impaired
cardiovagal and sympathetic vasomotor responses to
baroreceptor stimulation [8]. As a novel finding extending
beyond our previous ones, we showed that phase shift
analysis during 0.1 Hz neck suction is suited to identifying
subtle impairment of cerebrovascular regulation in patients
who have type 2 diabetes and autonomic neuropathy.
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